Cargando…
Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice
BACKGROUND: Highly pathogenic avian H5N1 influenza virus is a major public health concern. Given the lack of effective vaccine and recent evidence of antiviral drug resistance in some isolates, alternative strategies for containment of a possible future pandemic are needed. Humanized monoclonal anti...
Autores principales: | Hanson, Brendon J, Boon, Adrianus CM, Lim, Angeline PC, Webb, Ashley, Ooi, Eng Eong, Webby, Richard J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1626464/ https://www.ncbi.nlm.nih.gov/pubmed/17040574 http://dx.doi.org/10.1186/1465-9921-7-126 |
Ejemplares similares
-
Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library
por: Lim, Angeline PC, et al.
Publicado: (2008) -
Passive Broad-Spectrum Influenza Immunoprophylaxis
por: Berry, Cassandra M., et al.
Publicado: (2014) -
Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1
por: Lim, Angeline PC, et al.
Publicado: (2008) -
Dengue Virus Neutralization in Cells Expressing Fc Gamma Receptors
por: Chawla, Tanu, et al.
Publicado: (2013) -
Passive Immunoprophylaxis against Respiratory Syncytial Virus in Children: Where Are We Now?
por: Rocca, Alessandro, et al.
Publicado: (2021)